MURAE ORGANISOR
|
MURAE ORGANISOR Last 5 Year Financial Ratios History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 0.08 | - | 0.32 | 0.36 | 0.14 |
| CEPS(Rs) | 0.04 | - | 0.13 | 0.14 | 0.01 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 2.24 | 2.26 | 3.03 | 2.71 | 23.51 |
| Tax Rate(%) | 25.03 | 27.85 | 29.12 | 27.83 | 25.00 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 1.17 | -14.52 | 11.92 | -21.02 | -18.89 |
| EBIT Margin(%) | 1.17 | 10.48 | 20.64 | 15.04 | 2.55 |
| Pre Tax Margin(%) | 1.17 | 2.30 | 18.70 | 14.65 | 0.29 |
| PAT Margin (%) | 0.88 | 1.66 | 13.25 | 10.57 | 0.21 |
| Cash Profit Margin (%) | 0.88 | 3.50 | 13.95 | 11.13 | 0.51 |
| Performance Ratios | |||||
| ROA(%) | 1.95 | 0.07 | 6.91 | 7.85 | 0.28 |
| ROE(%) | 5.69 | 0.14 | 11.18 | 14.24 | 0.61 |
| ROCE(%) | 4.21 | 0.81 | 11.66 | 12.34 | 4.23 |
| Asset Turnover(x) | 2.22 | 0.04 | 0.52 | 0.74 | 1.28 |
| Sales/Fixed Asset(x) | - | - | 15.67 | 21.25 | 40.52 |
| Working Capital/Sales(x) | 2.03 | 0.06 | 0.82 | 1.30 | 2.55 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | - | - | 0.06 | 0.05 | 0.02 |
| Receivable days | 56.13 | 1,090.21 | 286.11 | 223.10 | 122.72 |
| Inventory Days | 2.94 | 1,442.82 | 309.92 | 240.43 | 128.19 |
| Payable days | 42.32 | -51.79 | 4.09 | 18.22 | 50.51 |
| Valuation Parameters | |||||
| PER(x) | 7.75 | 302.49 | 5.55 | 12.70 | - |
| PCE(x) | 17.05 | 315.23 | 6.24 | 14.27 | - |
| Price/Book(x) | 0.62 | 0.63 | 0.70 | 2.00 | - |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 0.34 | 7.38 | 1.45 | 2.00 | 0.42 |
| EV/Core EBITDA(x) | 29.33 | 59.90 | 6.81 | 12.83 | 14.89 |
| EV/EBIT(x) | 29.35 | 70.43 | 7.04 | 13.31 | 16.64 |
| EV/CE(x) | 0.70 | 0.42 | 0.79 | 1.65 | 0.68 |
| M Cap / Sales | 0.15 | 11.04 | 0.87 | 1.59 | - |
| Growth Ratio | |||||
| Net Sales Growth(%) | - | -78.58 | -28.94 | -48.80 | -25.45 |
| Core EBITDA Growth(%) | 2,443.72 | -87.63 | -2.82 | 180.24 | -66.64 |
| EBIT Growth(%) | 2,889.60 | -89.12 | -2.48 | 201.86 | -69.28 |
| PAT Growth(%) | - | -97.32 | -10.92 | 2,420.57 | -95.14 |
| EPS Growth(%) | 3,752.38 | -99.35 | -10.92 | 152.06 | -95.14 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 1.02 | - | 0.47 | 0.52 | 0.78 |
| Current Ratio(x) | 2.83 | 1.87 | 2.85 | 2.34 | 2.47 |
| Quick Ratio(x) | 2.82 | 1.68 | 1.52 | 1.32 | 1.06 |
| Interest Cover(x) | 2,640.29 | 1.28 | 10.63 | 38.44 | 1.13 |
| Total Debt/Mcap(x) | 1.66 | - | 0.67 | 0.26 | - |
Compare Financial Ratios of peers of MURAE ORGANISOR
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MURAE ORGANISOR | ₹49.1 Cr | -11.1% | -4% | -59.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹400,497.0 Cr | -3.5% | -6.4% | -2.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹165,492.0 Cr | -5.8% | -1.6% | 10.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,013.0 Cr | 1.4% | 7% | 23.7% | Stock Analytics | |
| CIPLA | ₹112,922.0 Cr | -4.7% | -6.8% | -0.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,115.0 Cr | -2.8% | -8.1% | -11.1% | Stock Analytics | |
MURAE ORGANISOR Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MURAE ORGANISOR | -11.1% |
-4% |
-59.8% |
| SENSEX | -0.7% |
-1.9% |
8% |
You may also like the below Video Courses
